サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1435156

自動注射器市場：治療法、製品タイプ、用途、エンドユーザー別-2024-2030年の世界予測

Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
自動注射器市場：治療法、製品タイプ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自動注射器市場規模は2023年に673億9,000万米ドルと推計され、2024年には806億2,000万米ドルに達し、CAGR 19.72%で2030年には2,377億米ドルに達すると予測されます。

自動注射器の世界市場

主な市場の統計
基準年[2023] 673億9,000万米ドル
予測年[2024］ 806億2,000万米ドル
予測年 [2030] 2,377億米ドル
CAGR（%） 19.72%
自動注射器 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは自動注射器市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、自動注射器市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-自動注射器市場の市場規模および予測は？

2-自動注射器市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-自動注射器市場における技術動向と規制の枠組みは？

4-自動注射器市場における主要ベンダーの市場シェアは？

5-自動注射器市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人口におけるアナフィラキシーの有病率の上昇
      • 注射の自己投与への関心の高まり
      • オンライン薬局チャネルを通じて広く入手可能
    • 抑制要因
      • 自動注射器デバイスの安全性と使いやすさに関する問題
    • 機会
      • 自動注射器の設計と技術の改善
      • 在宅医療サービスの普及拡大
    • 課題
      • 厳しい規制および承認要件
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 自動注射器市場：治療別

  • アナフィラキシー
  • 糖尿病
  • 多発性硬化症
  • 関節リウマチ

第7章 自動注射器市場：製品タイプ別

  • 使い捨て自動注射器
  • 再利用可能な自動注射器
    • 充填なし
    • 充填済み

第8章 自動注射器市場：用途別

  • アナフィラキシー
  • 貧血
  • 心血管疾患
  • 糖尿病
  • 片頭痛
  • 多発性硬化症
  • 乾癬
  • 関節リウマチ

第9章 自動注射器市場：エンドユーザー別

  • 外来手術センター
  • ホームケア用
  • 病院とクリニック

第10章 南北アメリカの自動注射器市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の自動注射器市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの自動注射器市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • Antares Pharma, Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Becton, Dickinson and Company
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline PLC
    • Harro Hofliger Verpackungsmaschinen GmbH
    • Johnson & Johnson Services, Inc.
    • Medeca Pharma AB
    • Merck KGaA
    • Mylan N.V. by Viatris Inc.
    • NEMERA Group
    • Novartis AG
    • Pfizer, Inc.
    • Ravimed Sp. z o.o.
    • Recipharm AB
    • Sanofi S.A.
    • SHL Medical AG
    • Stevanato Group
    • Teva Pharmaceutical Industries Ltd.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. AUTO-INJECTORS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTO-INJECTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTO-INJECTORS MARKET DYNAMICS
  • FIGURE 7. AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 8. AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 14. AUTO-INJECTORS MARKET SIZE, BY EMPTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AUTO-INJECTORS MARKET SIZE, BY PREFILLED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AUTO-INJECTORS MARKET SIZE, BY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 239. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. AUTO-INJECTORS MARKET LICENSE & PRICING
目次
Product Code: MRR-ED54C46E91F1

[189 Pages Report] The Auto-Injectors Market size was estimated at USD 67.39 billion in 2023 and expected to reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030.

Global Auto-Injectors Market

KEY MARKET STATISTICS
Base Year [2023] USD 67.39 billion
Estimated Year [2024] USD 80.62 billion
Forecast Year [2030] USD 237.70 billion
CAGR (%) 19.72%
Auto-Injectors Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-Injectors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Harro Hofliger Verpackungsmaschinen GmbH, Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Auto-Injectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy
    • Anaphylaxis
    • Diabetes
    • Multiple Sclerosis
    • Rheumatoid Arthritis
  • Product Type
    • Disposable Auto-Injectors
    • Reusable Auto-Injectors
      • Empty
      • Prefilled
  • Application
    • Anaphylaxis
    • Anemia
    • Cardiovascular Diseases
    • Diabetes
    • Migraines
    • Multiple Sclerosis
    • Psoriasis
    • Rheumatoid Arthritis
  • End-user
    • Ambulatory Surgical Centers
    • Homecare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Auto-Injectors Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-Injectors Market?

3. What are the technology trends and regulatory frameworks in the Auto-Injectors Market?

4. What is the market share of the leading vendors in the Auto-Injectors Market?

5. Which modes and strategic moves are suitable for entering the Auto-Injectors Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Auto-Injectors Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of anaphylaxis among population
      • 5.1.1.2. Growing inclination towards self-administration of injections
      • 5.1.1.3. Widespread availability through online pharmacy channels
    • 5.1.2. Restraints
      • 5.1.2.1. Issues pertaining to the safety and usability of auto-injectors devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvement in auto injector designs and technology
      • 5.1.3.2. Increasing penetration of home-care health services
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory and approval requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Auto-Injectors Market, by Therapy

  • 6.1. Introduction
  • 6.2. Anaphylaxis
  • 6.3. Diabetes
  • 6.4. Multiple Sclerosis
  • 6.5. Rheumatoid Arthritis

7. Auto-Injectors Market, by Product Type

  • 7.1. Introduction
  • 7.2. Disposable Auto-Injectors
  • 7.3. Reusable Auto-Injectors
    • 7.4.1. Empty
    • 7.4.2. Prefilled

8. Auto-Injectors Market, by Application

  • 8.1. Introduction
  • 8.2. Anaphylaxis
  • 8.3. Anemia
  • 8.4. Cardiovascular Diseases
  • 8.5. Diabetes
  • 8.6. Migraines
  • 8.7. Multiple Sclerosis
  • 8.8. Psoriasis
  • 8.9. Rheumatoid Arthritis

9. Auto-Injectors Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals & Clinics

10. Americas Auto-Injectors Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Auto-Injectors Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Auto-Injectors Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Amgen Inc.
    • 14.1.3. Antares Pharma, Inc.
    • 14.1.4. AstraZeneca PLC
    • 14.1.5. Bayer AG
    • 14.1.6. Becton, Dickinson and Company
    • 14.1.7. Biogen Inc.
    • 14.1.8. Bristol-Myers Squibb Company
    • 14.1.9. Eli Lilly and Company
    • 14.1.10. F. Hoffmann-La Roche Ltd.
    • 14.1.11. GlaxoSmithKline PLC
    • 14.1.12. Harro Hofliger Verpackungsmaschinen GmbH
    • 14.1.13. Johnson & Johnson Services, Inc.
    • 14.1.14. Medeca Pharma AB
    • 14.1.15. Merck KGaA
    • 14.1.16. Mylan N.V. by Viatris Inc.
    • 14.1.17. NEMERA Group
    • 14.1.18. Novartis AG
    • 14.1.19. Pfizer, Inc.
    • 14.1.20. Ravimed Sp. z o.o.
    • 14.1.21. Recipharm AB
    • 14.1.22. Sanofi S.A.
    • 14.1.23. SHL Medical AG
    • 14.1.24. Stevanato Group
    • 14.1.25. Teva Pharmaceutical Industries Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing